Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.

The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

Texas MPN Workshop 2020 | Myeloproliferative neoplasms in young patients

Nicole Kucine • 25 Aug 2020
Texas MPN Workshop 2020
Acute Myeloid Leukemia Essential Thrombocythemia Leukemia Myeloproliferative Neoplasms Polycythemia Vera Rare Diseases Interferon

Nicole Kucine, MD, MS, of Weill Cornell Medicine, New York, NY, discusses the incidence of myeloproliferative neoplasms in adolescent and pediatric patients, and differences in genetic profiles, treatment and outcomes between adult and younger patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nicole Kucine

Changing attitudes to using interferon in pediatric patients with MPNs
1:29
Changing attitudes to using interferon in pediatric patients with MPNs
Nicole Kucine • 27 Aug 2024
Important considerations when deciding whether a young patient with MPN should receive cytoreduction
2:31
Important considerations when deciding whether a young patient with MPN should receive cytoreduction
Nicole Kucine • 27 Aug 2024
Unmet needs and areas of investigation in the treatment of pediatric and AYA patients with MPNs
1:23
Unmet needs and areas of investigation in the treatment of pediatric and AYA patients with MPNs
Nicole Kucine • 27 Aug 2024
MPNs in pediatric and AYA patients
3:18
MPNs in pediatric and AYA patients
Nicole Kucine • 27 Aug 2024

Related Videos

Federated learning to train generative AI models for diagnosis & prognosis of hematological diseases
2:08
Federated learning to train generative AI models for diagnosis & prognosis of hematological diseases
Nicole Kucine • 7 Dec 2025
cAMeLot-2: Phase III trial of bleximenib + venetoclax + azacitidine in AML with KMT2A/NPM1 mutations
1:10
cAMeLot-2: Phase III trial of bleximenib + venetoclax + azacitidine in AML with KMT2A/NPM1 mutations
Nicole Kucine • 24 Nov 2025
Single-agent SC blinatumomab in R/R B-ALL: Phase I/II efficacy results with extended follow-up
1:16
Single-agent SC blinatumomab in R/R B-ALL: Phase I/II efficacy results with extended follow-up
Nicole Kucine • 24 Nov 2025
The ACCESS study: impact of HLA disparity on transplant outcomes in patients receiving MMUD grafts
2:53
The ACCESS study: impact of HLA disparity on transplant outcomes in patients receiving MMUD grafts
Nicole Kucine • 6 Dec 2025
The content of VJHemOnc is intended for healthcare professionals